Tecan and ForteBio Automate Label-Free assays for Bioprocess and Drug Discovery Applications

Mar 09, 2010

March 9, 2010 — Tecan has become ForteBio’s preferred automation partner for real-time, label-free assays to support bioprocess and drug discovery workflows. The two companies have worked together to integrate the new ForteBio Octet® 384 platform, consisting of the Octet RED384 and the Octet QK384, on Tecan’s Freedom EVO® liquid handling workstation. The result is a robust, off-the-shelf integration that offers increased walkaway time and optional liquid handling for assay plate set-up.


Tecan has designed a Freedom EVO deck extension plate to mount the Octet 384 instrument securely on the right hand side of the workstation. A robotic manipulator arm performs automated transport and handling of plates and sensor trays, and an 8-channel liquid handling arm with fixed or disposable tips is used to prepare assay plates. A MultiChannel Arm™ (MCA), with a 384- or 96-channel pipetting head, can also be specified for higher throughput applications. Kevin Moore, Tecan’s Director of Market and Application Management for BioPharma, said: “We are very pleased to be working with ForteBio to bring an automation solution to customers in this fast growing area of label-free detection.” ForteBio’s Octet platform enables reliable high throughput measurements for protein-protein, protein-peptide, protein-small molecule and fragment screening assays, using the innovative Dip and Read™ biosensors. The Octet systems use proprietary biolayer interferometry (BLI) to provide real-time, label-free analysis of biomolecular interactions. “We are delighted to partner with Tecan, enabling Octet customers to process batches of assay plates and automate sample handling for Dip and Read biosensor assays, allowing greater throughput and increased efficiency,” concluded Christopher Silva, ForteBio’s Vice President of Marketing.

About Tecan

Tecan (www.tecan.com) is a leading global provider of laboratory instruments and solutions in biopharmaceuticals, forensics, and clinical diagnostics. The company specializes in the development, production and distribution of automation solutions for laboratories in the life sciences sector. With its subsidiary REMP (www.remp.com), Tecan is the market leader in automated laboratory storage and logistics systems. Its clients include pharmaceutical and biotechnology companies, university research departments and diagnostic laboratories. Founded in Switzerland in 1980, the company has manufacturing, research and development sites in both North America and Europe and maintains a sales and service network in 52 countries. In 2008, Tecan generated sales of CHF 396 million (USD 366.7 million; EUR 250.7 million). Registered shares of Tecan Group are traded on the SIX Swiss Exchange (TK: TECN/Reuters: TECZn.S/Swiss security number: 1210019).

About ForteBio

ForteBio is a life science company that provides analytical systems to accelerate biotherapeutic drug discovery and development. These systems enable real-time, label-free analysis of biomolecular interactions, providing information on affinity, kinetics and concentration. ForteBio’s analytical capabilities enable significantly easier, faster and better characterization of drug candidates, thus providing greater value in drug development applications where existing methods have limitations in throughput, performance and cost. The company is headquartered in Menlo Park, California, with wholly owned subsidiaries in London and Shanghai. For more information, visit www.fortebio.com.

Contact Information :
Gemma Milan
650 322 1360

Contact Information 2:
Paul Saville
kdm communications limited
+44 (0) 1234 210555